Yangling, Shaanxi, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corp. (OTCQB: KWBT) (“Kiwa Bio-Tech” or “the Company”), an emerging agricultural company that develops and manufactures microbial fertilizers in China, is pleased to announced that it has retained Consulting for Strategic Growth 1 Ltd., a fully integrated Investor Relations firm with offices in New York, specializing in small-cap and emerging growth public and private companies, for strategic counseling and to begin a comprehensive investor relations program.
Investor relations activities will include shareholder analysis, research preparation, a stock awareness program including online promotion, as well as individual and group meetings with institutional and retail investors, and a targeted business and trade-oriented media relations program. With decades of hands-on-experience and broad personal outreach in the public and private investment communities, CFSG1 will focus on putting KIWA in front of the right investment decision-makers.
“We are very pleased to partner with Stan Wunderlich and his team at CFSG1, whose experience in counseling small cap companies, such as Kiwa Bio-Tech, is well known throughout the industry and for helping small businesses grow and achieve their long-term objectives,” stated Yvonne Wang, CEO of Kiwa Bio-Tech.
“CFSG1 has had considerable experience working with China-based companies, introducing them and their quality products to targeted investors within the United States. We are confident that they will help us gain recognition among investors and work to increase our shareholder base on Wall Street and throughout the U.S and additional European communities,” she added.
Stanley Wunderlich, Chief Executive Officer, CFSG1 and Launchpad, said, “We look forward to working with Yvonne and the rest of the experienced team at Kiwa Bio-Tech. Our insight and knowledge gained from working with many other Chinese companies in the past, will help us represent and present the company and its eco-friendly agricultural innovation modulation model to savvy and knowledgeable U.S. investors.”
About Kiwa Bio-Tech Products Group Corp.
Leader in Eco-Friendly Agricultural Industry Chain
Kiwa Bio-Tech Products Group Corp. (KWBT) is a publicly traded company with corporate headquarters in the Yangling, Shanxi, China. The company develops, manufactures, markets and distributes innovative and environmentally safe bio-technological products for agriculture. Kiwa’s focus is to positively impact the environment by reducing the amount of chemical fertilizers that are being used by agricultural growers in China.
Kiwa Bio-Tech Products Group Corp. products are covered by patent protection and are designed to enhance the quality of human life by increasing the value and productivity of agricultural crops.
For more information on Kiwa Bio-Tech Products Group Corp. or its bio-fertilizer products and smart soil remediation technology, please refer to the Company’s website at www.kiwabiotech.com or the Company filings with the United States Securities and Exchange Commission at www.sec.gov.
About CFSG1/Launchpad
Launchpad IR is a leader in emerging growth company corporate communications and investor relations. Our core business focuses on creating market awareness for domestic and international emerging growth companies.
With decades of hands-on corporate development experience and broad personal relationships including outreach in the private and public investment communities, we place our clients in front of the right decision-makers, market makers and financial gatekeepers – the ones who know your industry, care about your business.
Unlike traditional investor relations firms, Launchpad IR has no need to advertise its services. Our clients are referred to us by investment professionals because they understand that the rules of the game have changed. Investment bankers, retail brokerages and capital funds that focus on the micro-cap market understand the fragmented nature of the investor relations industry and the near obsolescence of reputable, performance-driven firms solely focused on small issuers.
We offer our clients a unique combination of strategic counsel, capital introductions and secondary market support services. Launchpad’s team is comprised of professionals with decades of Wall Street, investor relations and media experience. Coupled with a proactive partnering approach that aligns our interests with our clients’, Launchpad IR is the perfect starting point for early-stage companies seeking to build shareholder value.
Our years of experience allow us to guide your firm through the challenging and ever-changing capital markets. We allow you to not only take advantage of our relationships, but to also rely upon our experience to help get you company noticed in the crowded financial marketplace.
Forward-Looking Statements
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company’s estimates as of the date of the press release, and subsequent events and developments may cause the Company’s estimates to change. The Company’s actual results may differ materially from those anticipated in the forward-looking statements depending on a number of risk factors including, but not limited to, the following: general economic, business and environment conditions, development, shipment, market acceptance, additional competition from existing and new competitors, changes in technology, the execution of its ten-year growth plan, the foreign exchange risk amid the unexpected announcements by the PRC government and various other factors beyond the Company’s control. Kiwa Bio-Tech Products Group Corp. specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release.
Contact:
Kiwa Bio-Tech Products Group Corporation
Consulting for Strategic Growth 1, Ltd
Investor Relations
1-800-625-2236